We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Dillards
DDS
$8.87B
| $40.3M | 0.27% |
223,068
+57,196
| +34% | +$7.38M |
|
102
Service Corp International
SCI
$11.4B
| $40.3M | 0.27% |
752,373
+161,211
| +27% | +$8.56M |
|
103
Signet Jewelers
SIG
$3.55B
| $40M | 0.27% |
495,624
+14,026
| +3% | +$908K |
|
104
Voya Financial
VOYA
$8.94B
| $39.8M | 0.27% |
646,577
+180,451
| +39% | +$11.9M |
|
105
CBRE Group
CBRE
$40.8B
| $38.8M | 0.26% |
452,545
+66,702
| +17% | +$5.69M |
|
106
Medifast
MED
$108M
| $38.7M | 0.26% |
136,625
+8,588
| +7% | +$2.33M |
|
107
Jazz Pharmaceuticals
JAZZ
$15.9B
| $38.5M | 0.26% |
216,595
-8,598
| -4% | -$1.49M |
|
108
Markel Group
MKL
$25B
| $38.4M | 0.26% |
32,378
+15,312
| +90% | +$18.4M |
|
109
Kroger
KR
$34.8B
| $38.3M | 0.26% |
998,840
+126,217
| +14% | +$4.75M |
|
110
Emcor
EME
$33.1B
| $38.3M | 0.26% |
310,611
-55,916
| -15% | -$6.82M |
|
111
Ryder
R
$10.3B
| $38.2M | 0.26% |
514,573
+279,438
| +119% | +$22.1M |
|
112
Green Dot
GDOT
$753M
| $38.1M | 0.26% |
813,773
+22,592
| +3% | +$1.01M |
|
113
SLM Corp
SLM
$4.57B
| $37.4M | 0.25% |
1,787,457
-489,396
| -21% | -$9.64M |
|
114
Ashland
ASH
$3.04B
| $37.3M | 0.25% |
426,693
+30,691
| +8% | +$2.76M |
|
115
CVS Health
CVS
$137B
| $37.3M | 0.25% |
446,479
+437,523
| +4,885% | +$35.8M |
|
116
Olin
OLN
$2.64B
| $36.9M | 0.25% |
797,515
+750,647
| +1,602% | +$33.8M |
|
117
Popular Inc
BPOP
$11B
| $36.8M | 0.25% |
489,782
+61,191
| +14% | +$4.68M |
|
|
SAFM
118
DELISTED
Sanderson Farms Inc
SAFM
| $36.6M | 0.25% |
194,827
+101,235
| +108% | +$17M |
|
119
Northrop Grumman
NOC
$77B
| $35.6M | 0.24% |
98,010
+24,739
| +34% | +$8.91M |
|
120
News Corp Class A
NWSA
$14.5B
| $35.5M | 0.24% |
1,376,171
+478,610
| +53% | +$12.6M |
|
121
Chipotle Mexican Grill
CMG
$40.8B
| $35M | 0.24% |
1,127,700
+1,024,950
| +998% | +$29.2M |
|
|
P
122
Everpure Inc
P
$24.8B
| $34.4M | 0.23% |
1,762,405
+31,605
| +2% | +$621K |
|
|
TSE
123
DELISTED
Trinseo
TSE
| $34.1M | 0.23% |
569,331
+76,238
| +15% | +$4.87M |
|
124
Howard Hughes
HHH
$3.93B
| $34M | 0.23% |
365,828
+301,222
| +466% | +$29.8M |
|
|
POLY
125
DELISTED
Plantronics, Inc.
POLY
| $33.4M | 0.23% |
800,486
+35,887
| +5% | +$1.34M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.